NeoPharm Announces Fourth Quarter And Full Year 2009 Financial Results
LAKE BLUFF, Ill.--(BUSINESS WIRE)--NeoPharm, Inc. (Other OTC: NEOL.PK), a publicly traded biopharmaceutical company dedicated to the research, development and commercialization of new and innovative therapeutic applications of drugs for cancer and other diseases, today announced its fourth quarter and full year 2009 financial results.